$31.730
+2.561 (+8.07%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
QNCX Prediction & Forecast by Similar Chart Analysis
Alphio's QNCX stock price prediction model matches the current Quince Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $32.03 (+0.93%). The 1-week path is $33.58 (+5.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Quince Therapeutics Inc Stock?
Quince Therapeutics Inc is a good buy right now due to its recent positive momentum and analyst support. The stock has seen a 5-day change of +8.66% and is currently trading at $31.73, with a consensus target price of $81.09 suggesting a potential upside of 168.96%. Additionally, the RSI is at 66.39, indicating strong momentum. However, the main risk is the company's recent financial performance, as it reported a net income loss of $75,488,000 in Q2 2026, which could impact investor sentiment if not addressed.
QNCX stock price ended at $31.73 on Friday, after rising +8.07%
Quince Therapeutics Inc (QNCX) last closed at $31.73, gaining +8.07%. These facts feed the 1-day and 1-week QNCX price prediction above.
Forecast Drivers
Quince Therapeutics Inc (QNCX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches QNCX, ranked by similarity.
Seasonality analysis for QNCX
Historically the probability of a positive November return for QNCX is 71.79%. December offers the highest probability of a positive month at 100.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for QNCX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.62 | $2.00 | $2.05 | -93.70% |
| Dec 2026 | $1.32 | $1.69 | $1.78 | -94.68% |
In 2026, Quince Therapeutics Inc (QNCX) is projected to range from $1.32 to $2.05.
Quince Therapeutics Inc 2026 monthly forecast
In Nov 2026, Quince Therapeutics Inc is projected to average $2.00, with a low of $1.62 and high of $2.05.
In Dec 2026, Quince Therapeutics Inc is projected to average $1.69, with a low of $1.32 and high of $1.78.
Related articles
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
- Bitcoin Bear Market 2026: Why BTC Fell Below $70K and How Investors Can Manage Crypto RiskBitcoin is about 45% below its $126K peak as Fed hikes, 5% yields and ETF outflows bite. See how the 2026 bear market compares and how to manage crypto risk.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.